Christina K. Thambiah-Crossette

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short.

TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short.

Journal: Blood advances
Published: February 19, 2026

TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short.

TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short.

Journal: Blood advances
Published: February 19, 2026

Anticoagulation, Recurrent Thrombosis and Major bleeding in antiphospholipid syndrome: UK multicentre observational study.

Anticoagulation, Recurrent Thrombosis and Major bleeding in antiphospholipid syndrome: UK multicentre observational study.

Journal: Blood advances
Published: December 19, 2025

Anticoagulation, recurrent thrombosis, and major bleeding in antiphospholipid syndrome: UK multicenter observational study.

Anticoagulation, recurrent thrombosis, and major bleeding in antiphospholipid syndrome: UK multicenter observational study.

Journal: Blood advances
Published: December 19, 2025

Reporting haemostasis assays in IU/dL-A recommendation for harmonisation from the British Society for Haematology Haemostasis and Thrombosis Task Force, UK NEQAS for Blood Coagulation and the UK Haemophilia Centres Doctors Organisation.

Reporting haemostasis assays in IU/dL-A recommendation for harmonisation from the British Society for Haematology Haemostasis and Thrombosis Task Force, UK NEQAS for Blood Coagulation and the UK Haemophilia Centres Doctors Organisation.

Journal: British journal of haematology
Published: June 18, 2025

von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy.

von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy.

Journal: Haematologica
Published: August 16, 2024

Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome-Single Centre Observational Study in the United Kingdom.

Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome-Single Centre Observational Study in the United Kingdom.

Journal: Seminars in thrombosis and hemostasis
Published: November 01, 2022

Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients.

Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients.

Journal: Research and practice in thrombosis and haemostasis
Published: August 29, 2022

Lupus Anticoagulant and Cardiopulmonary Bypass.

Lupus Anticoagulant and Cardiopulmonary Bypass.

Journal: Seminars in thrombosis and hemostasis
Published: July 26, 2022

Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study.

Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study.

Journal: British journal of haematology
Published: July 10, 2021

Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination.

Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: June 11, 2021

The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 study.

The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 study.

Journal: British journal of haematology
Published: April 25, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026